Paclitaxel and Bavituximab in Treating Patients With HER2-Negative Metastatic Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01288261
Recruitment Status : Completed
First Posted : February 2, 2011
Last Update Posted : April 21, 2016
National Cancer Institute (NCI)
Information provided by (Responsible Party):
University of Arizona

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : May 2013
  Study Completion Date : July 2015